Sanofi (SNYNF) Gets a Buy From UBS
Goldman Sachs Reaffirms Their Hold Rating on Sanofi (SNYNF)
Research Alert: CFRA Keeps Buy Opinion On Ads Of Sanofi
TD Cowen Maintains Sanofi(SNY.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Sanofi (SNY)
Barclays Keeps Their Buy Rating on Sanofi (SNYNF)
Sanofi (SNYNF) Gets a Hold From J.P. Morgan
Sanofi's Strong Financial Performance and Promising R&D Pipeline Justify Buy Rating
Research Alert: Further Approval Of Dupixent To Sustain Growth, Guidance Confirmed
Analysts Conflicted on These Healthcare Names: Novo Nordisk (NVO) and Sanofi (OtherSNYNF)
Sanofi Initiated With an Outperform at BNP Paribas Exane
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and HealthStream (HSTM)
Sanofi's Strong Financial Performance and Promising Growth Prospects Earn a Buy Rating
Jefferies Remains a Buy on Sanofi (SNYNF)
Bernstein Sticks to Their Buy Rating for Sanofi (SNYNF)
Sanofi's Strong Growth Potential: Buy Rating Backed by Attractive Valuation and Robust Pipeline
TD Cowen Maintains Sanofi(SNY.US) With Hold Rating, Maintains Target Price $67
Cautious Hold Rating on Sanofi Due to Safety Concerns and Limited Growth Prospects for Qfitlia
J.P. Morgan Sticks to Its Hold Rating for Sanofi (SNYNF)
Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Sanofi (OtherSNYNF) and MacroGenics (MGNX)